Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPOG.L Regulatory News (POG)

  • There is currently no data for POG

Director/PDMR Shareholding

9 Nov 2016 16:42

RNS Number : 7918O
Petropavlovsk PLC
09 November 2016
 

 

09 November 2016

 

Directors' Shareholding

 

Petropavlovsk PLC (the "Company" and, together with its subsidiaries, the "Group") announces that it has been notified today by Mr. Peter Hambro, Chairman and Dr. Pavel Maslovskiy, CEO, of the information set out below.

 

As announced on 2 February 2015, Messrs Hambro and Maslovskiy entered into the Recapitalisation Agreement made between them, the Company and certain of the holders of the 2015 convertible Bonds under the terms of which they agreed to underwrite the issue of 395,491,398 ordinary shares of £0.01 in the Company ("the Shares") for US$30 million. In order to enable them to fulfil this obligation Vailaski Holdings Limited subscribed for the Shares and entered into an Option Agreement with Messrs. Hambro, Maslovskiy and their Russian business partner Mr. Andrei Vdovin covering put and call and voting rights in respect of the Shares (the "HMV Option").

 

Vailaski, in turn, obtained funding to finance its subscription from Asian Pacific Bank ("APB"). APB is one of the largest privately-owned banks in the Eastern part of the Russian Federation. Its shareholders include leading international financial institutions, such as International Finance Corporation and East Capital. A family trust, of which Mr. Hambro is a potential beneficiary, indirectly owns 23% of APB.

 

APB now requires Vailaski to restructure its holdings in the Company and accordingly Vailaski has sold 380,325,518 of its Shares in Petropavlovsk PLC to APB and is in the process of entering into an option agreement with APB in relation to these Shares. The terms of this option agreement will mirror those of the HMV Option, thus forming a back-to-back arrangement.

 

Accordingly, Messrs. Hambro's and Maslovskiy's exposure to Petropavlovsk Shares remains unchanged from that announced previously.

 

It should be noted that the 380,325,518 Ordinary Shares in Petropavlovsk PLC that have been acquired by APB are held on the books of APB as an investment asset and thus Messrs. Hambro and Maslovskiy, who are not part of the management of the bank and cannot influence its day to day decisions, do not have direct control over these shares and only retain their exposure to them through the HMV Option.

 

The table below shows the holdings of Mr. Hambro and his associated entities and Dr. Maslovskiy and his associated entities. They remain unchanged to the numbers previously disclosed.

 

 

 

 

 

Exposure to POG shares

% interest in voting rights

Mr. Peter Hambro and associated entities

 

152,280,861*

4.64

Dr. Pavel Maslovskiy and associated entities

 

190,774,346*

 

5.81

 

* The shares detailed in the above table include the voting rights over 131,830,466 Ordinary Shares over which Mr. Hambro and Dr. Maslovskiy each have put, call and voting rights pursuant to the HMV option as announced on 18 March 2015.

 

 

 

Enquiries

 

Petropavlovsk PLC

Alya Samokhvalova

Grace Hanratty

+44 (0) 20 7201 8900

 

Maitland

Neil Bennett

James Isola

+44 (0) 20 7379 5151

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFSSFMUFMSELF
Date   Source Headline
18th Jul 20224:38 pmRNSAppointment of Administrators
14th Jul 20222:53 pmRNSUpdate on Application to Appoint Administrators
12th Jul 20227:42 amRNSNotice of Application for an Administration Order
12th Jul 20227:30 amRNSSuspension - Petropavlovsk Plc
11th Jul 202210:11 amRNSUpdate on Convertible Bonds
4th Jul 202210:49 amRNSHolding(s) in Company
1st Jul 20224:09 pmRNSResignation of Auditor
27th Jun 20224:30 pmRNSMoscow Exchange Listing Level Re-classification
7th Jun 202212:34 pmRNSChange of Accounting Reference Date & Corp. Update
23rd May 20224:40 pmRNSSecond Price Monitoring Extn
23rd May 20224:35 pmRNSPrice Monitoring Extension
20th May 20224:41 pmRNSSecond Price Monitoring Extn
20th May 20224:36 pmRNSPrice Monitoring Extension
18th May 20224:41 pmRNSSecond Price Monitoring Extn
18th May 20224:36 pmRNSPrice Monitoring Extension
17th May 20224:40 pmRNSSecond Price Monitoring Extn
17th May 20224:35 pmRNSPrice Monitoring Extension
16th May 202211:47 amRNSUpdate on Gazprombank Debt
13th May 20224:40 pmRNSSecond Price Monitoring Extn
13th May 20224:35 pmRNSPrice Monitoring Extension
12th May 20228:45 amRNSUpdate on Debt and Gold Sales
29th Apr 202211:08 amRNSUpdate on Guaranteed Notes and Convertible Bonds
27th Apr 20224:41 pmRNSSecond Price Monitoring Extn
27th Apr 20224:36 pmRNSPrice Monitoring Extension
25th Apr 20224:35 pmRNSPrice Monitoring Extension
22nd Apr 20224:40 pmRNSSecond Price Monitoring Extn
22nd Apr 20224:35 pmRNSPrice Monitoring Extension
22nd Apr 20227:00 amRNSQ1 2022 Production and Sales Report
20th Apr 20224:41 pmRNSSecond Price Monitoring Extn
20th Apr 20224:35 pmRNSPrice Monitoring Extension
20th Apr 20227:00 amRNSUpdate Regarding Gazprombank
19th Apr 20224:41 pmRNSSecond Price Monitoring Extn
19th Apr 20224:36 pmRNSPrice Monitoring Extension
14th Apr 20224:41 pmRNSSecond Price Monitoring Extn
14th Apr 20224:35 pmRNSPrice Monitoring Extension
14th Apr 20227:00 amRNSUpdate Regarding Gazprombank and Corporate Options
12th Apr 20224:40 pmRNSSecond Price Monitoring Extn
12th Apr 20224:35 pmRNSPrice Monitoring Extension
11th Apr 20227:00 amRNSBoard Update
8th Apr 20224:41 pmRNSSecond Price Monitoring Extn
8th Apr 20224:36 pmRNSPrice Monitoring Extension
7th Apr 202212:44 pmRNSHolding(s) in Company
6th Apr 202210:47 amRNSHolding(s) in Company Replacement
5th Apr 20226:20 pmRNSHolding(s) in Company
4th Apr 20224:40 pmRNSSecond Price Monitoring Extn
4th Apr 20224:36 pmRNSPrice Monitoring Extension
4th Apr 20223:52 pmRNSBoard Update
1st Apr 20227:00 amRNSNotice of Change to Director Details
30th Mar 20224:40 pmRNSSecond Price Monitoring Extn
30th Mar 20224:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.